Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1965 15
1966 25
1967 25
1968 26
1969 27
1970 27
1971 33
1972 35
1973 49
1974 75
1975 91
1976 82
1977 94
1978 98
1979 99
1980 117
1981 132
1982 87
1983 130
1984 91
1985 105
1986 165
1987 122
1988 118
1989 129
1990 164
1991 166
1992 146
1993 152
1994 160
1995 161
1996 182
1997 183
1998 198
1999 229
2000 217
2001 184
2002 167
2003 214
2004 194
2005 206
2006 232
2007 258
2008 246
2009 238
2010 249
2011 260
2012 254
2013 266
2014 267
2015 267
2016 246
2017 219
2018 211
2019 201
2020 214
2021 184
2022 196
2023 157
2024 157
2025 187
2026 54

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8,850 results

Results by year

Filters applied: . Clear all
Page 1
Measurement of pain.
Huskisson EC. Huskisson EC. Lancet. 1974 Nov 9;2(7889):1127-31. doi: 10.1016/s0140-6736(74)90884-8. Lancet. 1974. PMID: 4139420 Clinical Trial. No abstract available.
Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial.
Gaziano JM, Brotons C, Coppolecchia R, Cricelli C, Darius H, Gorelick PB, Howard G, Pearson TA, Rothwell PM, Ruilope LM, Tendera M, Tognoni G; ARRIVE Executive Committee. Gaziano JM, et al. Lancet. 2018 Sep 22;392(10152):1036-1046. doi: 10.1016/S0140-6736(18)31924-X. Epub 2018 Aug 26. Lancet. 2018. PMID: 30158069 Free PMC article. Clinical Trial.
BACKGROUND: The use of aspirin in the primary prevention of cardiovascular events remains controversial. We aimed to assess the efficacy and safety of aspirin versus placebo in patients with a moderate estimated risk of a first cardiovascular event. ...Nonetheless, …
BACKGROUND: The use of aspirin in the primary prevention of cardiovascular events remains controversial. We aimed to assess the effic …
Aspirin and serum estrogens in postmenopausal women: a randomized controlled clinical trial.
Duggan C, Wang CY, Xiao L, McTiernan A. Duggan C, et al. Cancer Prev Res (Phila). 2014 Sep;7(9):906-12. doi: 10.1158/1940-6207.CAPR-14-0109. Epub 2014 Jun 12. Cancer Prev Res (Phila). 2014. PMID: 24924486 Free PMC article. Clinical Trial.
Epidemiologic studies suggest a reduced risk of breast cancer among women who use aspirin. A plausible mechanism is through aspirin's effect on estrogens, possibly mediated through interference with estrogen synthesis via reduction in inflammation, which is i …
Epidemiologic studies suggest a reduced risk of breast cancer among women who use aspirin. A plausible mechanism is through aspiri …
Aspirin platelet reactivity on platelet function and clinical outcome in minor stroke or transient ischemic attack.
Xu Y, Chen W, Jiang L, Wang Y, Zhao X, Liu L, Yao D, Guo L, Wang Y, Pan Y, Wang Y. Xu Y, et al. J Stroke Cerebrovasc Dis. 2022 Sep;31(9):106683. doi: 10.1016/j.jstrokecerebrovasdis.2022.106683. Epub 2022 Jul 30. J Stroke Cerebrovasc Dis. 2022. PMID: 35914511 Free article. Clinical Trial.
MATERIALS AND METHODS: Patients with mild stroke or TIA were randomized into aspirin+ticagrelor, or aspirin+clopidogrel groups; aspirin reaction units (ARU) were measured at the baseline and after 7 2 days to assess response to treatment. ...Major bleeding …
MATERIALS AND METHODS: Patients with mild stroke or TIA were randomized into aspirin+ticagrelor, or aspirin+clopidogrel groups …
Omalizumab for Aspirin Hypersensitivity and Leukotriene Overproduction in Aspirin-exacerbated Respiratory Disease. A Randomized Controlled Trial.
Hayashi H, Fukutomi Y, Mitsui C, Kajiwara K, Watai K, Kamide Y, Nakamura Y, Hamada Y, Tomita Y, Sekiya K, Tsuburai T, Izuhara K, Wakahara K, Hashimoto N, Hasegawa Y, Taniguchi M. Hayashi H, et al. Am J Respir Crit Care Med. 2020 Jun 15;201(12):1488-1498. doi: 10.1164/rccm.201906-1215OC. Am J Respir Crit Care Med. 2020. PMID: 32142372 Free PMC article. Clinical Trial.
Systemic corticosteroid therapy does not completely suppress lifelong aspirin hypersensitivity. Omalizumab efficacy against aspirin-exacerbated respiratory disease has not been investigated in a randomized manner.Objectives: To evaluate omalizumab efficacy against …
Systemic corticosteroid therapy does not completely suppress lifelong aspirin hypersensitivity. Omalizumab efficacy against aspiri …
Low-dose aspirin-induced ulceration is attenuated by aspirin-phosphatidylcholine: a randomized clinical trial.
Cryer B, Bhatt DL, Lanza FL, Dong JF, Lichtenberger LM, Marathi UK. Cryer B, et al. Am J Gastroenterol. 2011 Feb;106(2):272-7. doi: 10.1038/ajg.2010.436. Epub 2010 Nov 16. Am J Gastroenterol. 2011. PMID: 21081908 Clinical Trial.
OBJECTIVES: Relative contributions of local and systemic mechanisms of upper gastrointestinal (GI) injury following aspirin are unknown. Studies suggest that aspirin's GI risk is age related and that gastroprotection may be needed at therapy initiation. ...Lo …
OBJECTIVES: Relative contributions of local and systemic mechanisms of upper gastrointestinal (GI) injury following aspirin are unkno …
Low-dose aspirin and incidence of colorectal tumors in a randomized trial.
Gann PH, Manson JE, Glynn RJ, Buring JE, Hennekens CH. Gann PH, et al. J Natl Cancer Inst. 1993 Aug 4;85(15):1220-4. doi: 10.1093/jnci/85.15.1220. J Natl Cancer Inst. 1993. PMID: 8331682 Clinical Trial.
Cox proportional hazards models were used to estimate relative risk (RR), 95% confidence intervals (CIs), and the association between aspirin and bleeding. Differences between aspirin and placebo groups in tumor risk over time were visualized with Kaplan-Meier curve …
Cox proportional hazards models were used to estimate relative risk (RR), 95% confidence intervals (CIs), and the association between asp …
Long-term treatment with aspirin desensitization: a prospective clinical trial comparing 100 and 300 mg aspirin daily.
Rozsasi A, Polzehl D, Deutschle T, Smith E, Wiesmiller K, Riechelmann H, Keck T. Rozsasi A, et al. Allergy. 2008 Sep;63(9):1228-34. doi: 10.1111/j.1398-9995.2008.01658.x. Allergy. 2008. PMID: 18699939 Clinical Trial.
BACKGROUND: The daily dose of aspirin in desensitization in aspirin-sensitive asthmatics with nasal polyps is still a matter of debate. ...METHODS: Patients with positive aspirin provocation test were treated with either 100 or 300 mg aspirin daily. RE …
BACKGROUND: The daily dose of aspirin in desensitization in aspirin-sensitive asthmatics with nasal polyps is still a matter o …
Aspirin after myocardial infarction.
[No authors listed] [No authors listed] Lancet. 1980 May 31;1(8179):1172-3. Lancet. 1980. PMID: 6103990 Clinical Trial. No abstract available.
Aspirin desensitization in patients with aspirin-induced and aspirin-tolerant asthma: a double-blind study.
Świerczyńska-Krępa M, Sanak M, Bochenek G, Stręk P, Ćmiel A, Gielicz A, Plutecka H, Szczeklik A, Niżankowska-Mogilnicka E. Świerczyńska-Krępa M, et al. J Allergy Clin Immunol. 2014 Oct;134(4):883-90. doi: 10.1016/j.jaci.2014.02.041. Epub 2014 Apr 24. J Allergy Clin Immunol. 2014. PMID: 24767875 Clinical Trial.
BACKGROUND: Numerous open trials have demonstrated the beneficial clinical effects of aspirin desensitization (AD) in patients with aspirin-induced asthma (AIA). These beneficial effects might be attributable to aspirin's potent anti-inflammatory prope …
BACKGROUND: Numerous open trials have demonstrated the beneficial clinical effects of aspirin desensitization (AD) in patients with …
8,850 results